Works by Nielsen, Dorte L.

Results: 30

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy.

Published in:

Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133250

By:

Lindgaard, Sidsel C.;
Maag, Emil;
Sztupinszki, Zsófia;
Chen, Inna M.;
Johansen, Astrid Z.;
Jensen, Benny V.;
Bojesen, Stig E.;
Nielsen, Dorte L.;
Szallasi, Zoltan;
Johansen, Julia S.

Publication type:

Article

Old age and poor prognosis increase the likelihood of disagreement between cancer patients and their oncologists on the indication for resuscitation attempt.

Published in:

2013

By:

Saltbaek, Lena;
Michelsen, Hanne M;
Nelausen, Knud M;
Gut, Rikke;
Nielsen, Dorte L

Publication type:

journal article

Work ability following breast cancer -- the MyHealth randomized controlled trial.

Published in:

Acta Oncologica, 2025, v. 646, p. 34, doi. 10.2340/1651-226X.2025.42221

By:

Horsbøl, Trine A.;
Saltbæk, Lena;
Urhammer, Caroline;
Karlsen, Randi V.;
Johansen, Christoffer;
Bidstrup, Pernille E.;
Høeg, Beverley L.;
Zoffmann, Vibeke;
Belmonte, Federica;
Andersen, Ingelise;
Friberg, Anne S.;
Svendsen, Mads N.;
Christensen, Helle G.;
Glavicic, Vesna;
Nielsen, Dorte L.;
Dalton, Susanne O.

Publication type:

Article

Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study.

Published in:

Acta Oncologica, 2018, v. 57, n. 11, p. 1445, doi. 10.1080/0284186X.2018.1531299

By:

Lund, Cecilia M.;
Vistisen, Kirsten K.;
Dehlendorff, Christian;
Rønholt, Finn;
Johansen, Julia S.;
Nielsen, Dorte L.

Publication type:

Article

Effect of Exercise on Physical Function and Psychological Well-being in Older Patients With Colorectal Cancer Receiving Chemotherapy-A Systematic Review.

Published in:

2020

By:

Lund, Cecilia M.;
Dolin, Troels G.;
Mikkelsen, Marta K.;
Juhl, Carsten B.;
Vinther, Anders;
Nielsen, Dorte L.

Publication type:

journal article

Determination of temporal reproducibility and variability of cancer biomarkers in serum and EDTA plasma samples using a proximity extension assay.

Published in:

Clinical Proteomics, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12014-022-09380-y

By:

Christensen, Troels D.;
Maag, Emil;
Madsen, Kasper;
Lindgaard, Sidsel Christy;
Nielsen, Dorte L.;
Johansen, Julia S.

Publication type:

Article

Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer.

Published in:

International Journal of Cardiovascular Imaging, 2010, v. 26, n. 2, p. 217, doi. 10.1007/s10554-009-9518-2

By:

Appel, Jon M.;
Jensen, Benny V.;
Nielsen, Dorte L.;
Ryberg, Marianne;
Zerahn, Bo

Publication type:

Article

Cancer patients, physicians, and nurses differ in their attitudes toward the decisional role in do-not-resuscitate decision-making.

Published in:

Supportive Care in Cancer, 2020, v. 28, n. 12, p. 6057, doi. 10.1007/s00520-020-05460-7

By:

Saltbæk, Lena;
Michelsen, Hanne M.;
Nelausen, Knud M.;
Theile, Susann;
Dehlendorff, Christian;
Dalton, Susanne O.;
Nielsen, Dorte L.

Publication type:

Article

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.

Published in:

BMC Pharmacology & Toxicology, 2014, v. 15, n. 1, p. 47, doi. 10.1186/2050-6511-15-47

By:

Polk, Anne;
Vistisen, Kirsten;
Vaage-Nilsen, Merete;
Nielsen, Dorte L.

Publication type:

Article

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer.

Published in:

International Journal of Cancer, 2023, v. 152, n. 10, p. 2145, doi. 10.1002/ijc.34420

By:

Eefsen, Rikke Løvendahl;
Larsen, Jim S.;
Klarskov, Louise L.;
Altaf, Rahim;
Høgdall, Estrid;
Ingeholm, Peter;
Lykke, Jakob;
Nielsen, Dorte L.;
Pfeiffer, Per;
Poulsen, Laurids Ø.;
Qvortrup, Camilla;
Schou, Jakob V.;
Mau‐Sørensen, Morten;
Østerlind, Kell;
Jensen, Benny V.

Publication type:

Article

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.

Published in:

International Journal of Cancer, 2021, v. 148, n. 10, p. 2542, doi. 10.1002/ijc.33448

By:

Jensen, Benny Vittrup;
Schou, Jakob V.;
Yilmaz, Mette;
Johannesen, Helle H.;
Skougaard, Kristin;
Linnemann, Dorte;
Hogdall, Estrid V.;
Larsen, Finn O.;
Johansen, Julia S.;
Pfeiffer, Per;
Nielsen, Dorte L.

Publication type:

Article

Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up.

Published in:

International Journal of Cancer, 2020, v. 146, n. 7, p. 2019, doi. 10.1002/ijc.32847

By:

Abrahamsson, Hanna;
Jensen, Benny V.;
Berven, Lise L.;
Nielsen, Dorte L.;
Šaltytė Benth, Jūratė;
Johansen, Jakob S.;
Larsen, Finn O.;
Johansen, Julia S.;
Ree, Anne H.

Publication type:

Article

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 499, doi. 10.1186/1471-2407-14-360

By:

Levin Jørgensen, Charlotte;
Bjerre, Christina;
Ejlertsen, Bent;
Bjerre, Karsten D.;
Balslev, Eva;
Bartels, Annette;
Brünner, Nils;
Nielsen, Dorte L.

Publication type:

Article

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-360

By:

Jørgensen, Charlotte Levin Tykjær;
Bjerre, Christina;
Ejlertsen, Bent;
Bjerre, Karsten D.;
Balslev, Eva;
Bartels, Annette;
Brünner, Nils;
Nielsen, Dorte L.

Publication type:

Article

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Published in:

2014

By:

Jørgensen, Charlotte Levin Tykjær;
Bjerre, Christina;
Ejlertsen, Bent;
Bjerre, Karsten D;
Balslev, Eva;
Bartels, Annette;
Brünner, Nils;
Nielsen, Dorte L

Publication type:

journal article

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.

Published in:

2013

By:

Jørgensen, Charlotte L. T.;
Ejlertsen, Bent;
Bjerre, Karsten D.;
Balslev, Eva;
Nielsen, Dorte L.;
Nielsen, Kirsten V.

Publication type:

journal article

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.

Published in:

Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1228907

By:

Johansen, Astrid Z.;
Novitski, Sif I.;
Hjaltelin, Jessica X.;
Theile, Susann;
Boisen, Mogens K.;
Brunak, Søren;
Madsen, Daniel H.;
Nielsen, Dorte L.;
Chen, Inna M.

Publication type:

Article

Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.

Published in:

International Journal of Cancer, 2019, v. 144, n. 10, p. 2578, doi. 10.1002/ijc.31969

By:

Asleh, Karama;
Lyck Carstensen, Stina;
Tykjær Jørgensen, Charlotte L.;
Burugu, Samantha;
Gao, Dongxia;
Won, Jennifer R.;
Jensen, Maj‐Britt;
Balslev, Eva;
Lænkholm, Anne‐Vibeke;
Nielsen, Dorte L.;
Ejlertsen, Bent;
Nielsen, Torsten O.

Publication type:

Article

Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.

Published in:

International Journal of Cancer, 2015, v. 137, n. 8, p. 2000, doi. 10.1002/ijc.29556

By:

Kümler, Iben;
Balslev, Eva;
Poulsen, Tim S.;
Nielsen, Signe Lykke;
Nygård, Sune Boris;
Rømer, Maria Unni;
Christensen, Ib Jarle;
Høgdall, Estrid;
Moreira, José;
Nielsen, Dorte L.;
Brünner, Nils;
Stenvang, Jan

Publication type:

Article

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival.

Published in:

International Journal of Cancer, 2008, v. 122, n. 4, p. 857, doi. 10.1002/ijc.23152

By:

Roslind, Anne;
Johansen, Julia S.;
Christensen, Ib J.;
Kiss, Katalin;
Balslev, Eva;
Nielsen, Dorte L.;
Bentzen, Jens;
Price, Paul A.;
Andersen, Elo

Publication type:

Article

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer.

Published in:

2014

By:

Tuxen, Malgorzata K.;
Nielsen, Dorte L.;
Cold, Soeren;
Tange, Ulla B.;
Balslev, Eva

Publication type:

Journal Article

Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer.

Published in:

Acta Oncologica, 2014, v. 53, n. 10, p. 1440, doi. 10.3109/0284186X.2014.921727

By:

Tuxen, Malgorzata K.;
Nielsen, Dorte L.;
Cold, Soeren;
Tange, Ulla B.;
Balslev, Eva

Publication type:

Article

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Published in:

Acta Oncologica, 2014, v. 53, n. 6, p. 776, doi. 10.3109/0284186X.2013.865076

By:

Jørgensen, Charlotte L. T.;
Nielsen, Torsten O.;
Bjerre, Karsten D.;
Liu, Shuzhen;
Wallden, Brett;
Balslev, Eva;
Nielsen, Dorte L.;
Ejlertsen, Bent

Publication type:

Article

Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer.

Published in:

Acta Oncologica, 2012, v. 51, n. 8, p. 1054, doi. 10.3109/0284186X.2012.702920

By:

Appel, Jon M.;
Zerahn, Bo;
Møller, Susanne;
Christensen, Heidi M.;
Søgaard, Peter;
Ejlertsen, Bent;
Fogh-Andersen, Niels;
Jensen, Benny V.;
Nielsen, Dorte L.

Publication type:

Article

Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports.

Published in:

2006

By:

Nielsen, Dorte L.;
Pfeiffer, Per;
Jensen, Benny Vittrup

Publication type:

Letter

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study.

Published in:

Acta Oncologica, 2002, v. 41, n. 7/8, p. 675, doi. 10.1080/028418602321028300

By:

Svane, Inge M.;
Homburg, Keld M.;
Kamby, Claus;
Nielsen, Dorte L.;
Roer, Ole;
Sliffsgaard, Dorte;
Johnsen, Hans E.;
Hansen, Steen W.

Publication type:

Article

miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3<sup>rd</sup> Line Cetuximab and Irinotecan.

Published in:

PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099886

By:

Schou, Jakob V.;
Rossi, Simona;
Jensen, Benny V.;
Nielsen, Dorte L.;
Pfeiffer, Per;
Høgdall, Estrid;
Yilmaz, Mette;
Tejpar, Sabine;
Delorenzi, Mauro;
Kruhøffer, Mogens;
Johansen, Julia S.

Publication type:

Article

Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial.

Published in:

Oncologist, 2022, v. 27, n. 1, p. 67, doi. 10.1002/onco.13970

By:

Mikkelsen, Marta K;
Lund, Cecilia M;
Vinther, Anders;
Tolver, Anders;
Johansen, Julia S;
Chen, Inna;
Ragle, Anne-Mette;
Zerahn, Bo;
Engell-Noerregaard, Lotte;
Larsen, Finn O;
Theile, Susann;
Nielsen, Dorte L;
Jarden, Mary

Publication type:

Article

Myocardial Ischemia Induced by 5‐Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.

Published in:

Oncologist, 2021, v. 26, n. 3, p. e403, doi. 10.1002/onco.13536

By:

Dyhl‐Polk, Anne;
Schou, Morten;
Vistisen, Kirsten K.;
Sillesen, Anne‐Sophie;
Serup‐Hansen, Eva;
Faber, Jens;
Klausen, Tobias W.;
Bojesen, Stig E.;
Vaage‐Nilsen, Merete;
Nielsen, Dorte L.

Publication type:

Article

Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers.

Published in:

Clinical Chemistry, 2013, v. 59, n. 1, p. 52, doi. 10.1373/clinchem.2011.180778

By:

Sölétormos, György;
Duffy, Michael J.;
Hayes, Daniel F.;
Sturgeon, Catharine M.;
Barak, Vivian;
Bossuyt, Patrick M.;
Diamandis, Eleftherios P.;
Gion, Massimo;
Hyltoft-Petersen, Per;
Lamerz, Rolf M.;
Nielsen, Dorte L.;
Sibley, Paul;
Tholander, Bengt;
Tuxen, Malgorzata K.;
Bonfrer, Johannes M. G.

Publication type:

Article